At Geistek, we provide comprehensive regulatory expertise that guides your product from early development to global market authorization.
We combine scientific rigor, regulatory precision, and operational excellence to help biotech, pharma, and medical device companies achieve first-time-quality submissions and faster approvals with major authorities such as EMA, FDA, and COFEPRIS.
Our experts design tailored global regulatory strategies, integrating clinical, nonclinical, and manufacturing perspectives to ensure alignment with agency expectations.
We identify optimal pathways, mitigate risk early, and leverage accelerated designations (e.g., FDA Breakthrough Therapy, EMA PRIME, Orphan Drug status).
We ensure every decision moves your product closer to approval, efficiently and strategically.
Geistek delivers regulatory-ready submissions that meet regional standards and global expectations.
Our teams manage the complete submission process, from authoring and compiling dossiers to validation and eCTD publishing.
We transform complex data into clear, compliant, and approvable dossiers.
Our Regulatory Affairs professionals act as liaisons with agencies worldwide, guiding you through key milestones and representing your interests directly with regulators.
We build trust with regulators through clarity, science, and preparation.
Geistek continuously monitors global regulatory landscapes, distilling insights into actionable strategies.
Our Regulatory Intelligence platform tracks new guidelines, regional updates, and emerging expectations across 100+ markets.
We help you anticipate change, not react to it.
Our partnership continues after market authorization.
Geistek provides ongoing lifecycle management to maintain compliance and enable global expansion.
We ensure your approved products remain compliant, optimized, and globally accessible.
